Conjugation
of individual nanomaterials to form “nanohybrids”
has been the recent focus of advanced material synthesis with the
aim to achieve enhanced properties and synergistic functionalities.
However, nanohybrids may induce uncertain and unknown biological interactions
and toxicological responses that are likely to be unique and altered
from their component nanomaterial attributes. In this study, reduced
graphene oxide-nanoscale zerovalent iron (rGO-nZVI), a multifunctional
nanohybrid with promise for environmental remediation, has been systematically
evaluated for in vitro toxicity to human bronchial
epithelial cells (BEAS-2B). Careful synthesis of rGO-nZVI was performed
by chemical coreduction of graphene oxide (GO) and iron salt precursors,
followed by evaluation of their physicochemical properties and colloidal
stability in the biological media. A comprehensive assessment of biological
interactions and toxicological outcomes of rGO-nZVI and its parent
materials, i.e., GO, rGO, and nZVI on BEAS-2B cells included cellular
uptake, cell viability, cell membrane integrity, reactive oxygen species
(ROS) generation, and cell cycle analyses. The toxic behavior of rGO-nZVI
nanohybrids was found to be in between that of rGO/GO (most toxic)
and nZVI (least toxic); however, it was majorly governed by rGO/GO
toxicity and its mechanisms. This study sheds light on the importance
of sustainable design strategies for the next-generation complex and
hierarchical nanostructures.